Xing, Z., Li, X., He, Z. N. T., Fang, X., Liang, H., Kuang, C., . . . Yang, Q. (2024). IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG.
Chicago-viite (17. p.)Xing, Zikang, Xuewen Li, Zhen Ning Tony He, Xin Fang, Heng Liang, Chunxiang Kuang, Aiying Li, ja Qing Yang. IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG, 2024.
MLA-viite (9. p.)Xing, Zikang, et al. IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG, 2024.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.